EBS Competitors & Alternatives

Compare Emergent Biosolutions Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EBS

Main Stock
$5.16
Tradestie Score
56
Market Cap
$490.30M
Revenue Growth
0.7%
Analyst Upside
+113.2%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 48 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$24.90
$1.14B 67.7 59 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$27.77
$1.11B 21.7 56 Compare
CRON Cronos Group Inc. Common Share
$3.35
$1.02B 16.9 33 Compare
VIR Vir Biotechnology, Inc. Common Stock
$9.84
$791.82M - 37 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.66
$711.32M - 35 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$65.25
$543.32M 157.7 40 Compare
EOLS Evolus, Inc. Common Stock
$8.42
$397.82M - 27 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.19
$237.15M 5.5 51 Compare

Data updated: Aug 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry